ArticleFrontiers in oncology2019

Spliced XBP1 Levels Determine Sensitivity of Multiple Myeloma Cells to Proteasome Inhibitor Bortezomib Independent of the Unfolded Protein Response Mediator GRP78.

Bojana Borjan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.